Literature DB >> 24857392

Antimicrobial stewardship in immunocompromised hosts.

Lilian M Abbo1, Ella J Ariza-Heredia2.   

Abstract

The global spread of antimicrobial resistance has limited the availability of antimicrobial agents to treat infections that affect immunocompromised hosts. Efforts to optimize the selection, dosing, and duration of antimicrobial therapy to improve patient outcomes and minimize selective pressure on antimicrobial resistance are relevant to immunocompromised patients. Collaborative efforts between health care providers with expertise in the diagnosis and treatment of patients with various degrees of immunosuppression are pivotal for the success of antimicrobial stewardship programs in immunocompromised patients.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimicrobial stewardship; Fever; Hematologic malignancies; Immunocompromised; Neutropenia; Solid organ; Transplant

Mesh：

Substances：

Year:  2014        PMID： 24857392     DOI： 10.1016/j.idc.2014.01.008

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN： 0891-5520            Impact factor:   5.982


  18 in total

Review 1.  Antifungal stewardship considerations for adults and pediatrics.

Authors:  Rana F Hamdy; Theoklis E Zaoutis; Susan K Seo
Journal:  Virulence       Date:  2016-09-02       Impact factor: 5.882

Review 2.  Antimicrobial therapy in resource-limited settings with high antimicrobial resistance: a case-based approach.

Authors:  Nitin Gupta
Journal:  Infez Med       Date:  2022-03-01

3.  Antimicrobial Use in Pediatric Oncology and Hematology: Protocol for a Multicenter Point-Prevalence Study With Qualitative Expert Panel Assessment.

Authors:  Cihan Papan; Katharina Reifenrath; Katharina Last; Andishe Attarbaschi; Norbert Graf; Andreas H Groll; Johannes Huebner; Hans-Jürgen Laws; Thomas Lehrnbecher; Johannes Liese; Luise Martin; Tobias Tenenbaum; Stefan Weichert; Simon Vieth; Ulrich von Both; Markus Hufnagel; Arne Simon
Journal:  JMIR Res Protoc       Date:  2022-06-20

4.  Current State of Antimicrobial Stewardship at Solid Organ and Hematopoietic Cell Transplant Centers in the United States.

Authors:  Susan K Seo; Kaming Lo; Lilian M Abbo
Journal:  Infect Control Hosp Epidemiol       Date:  2016-07-26       Impact factor: 3.254

5.  Towards a global definition of responsible antibiotic use: results of an international multidisciplinary consensus procedure.

Authors:  Annelie A Monnier; Barry I Eisenstein; Marlies E Hulscher; Inge C Gyssens
Journal:  J Antimicrob Chemother       Date:  2018-06-01       Impact factor: 5.790

Review 6.  Expanding Existing Antimicrobial Stewardship Programs in Pediatrics: What Comes Next.

Authors:  Matthew P Kronman; Ritu Banerjee; Jennifer Duchon; Jeffrey S Gerber; Michael D Green; Adam L Hersh; David Hyun; Holly Maples; Colleen B Nash; Sarah Parker; Sameer J Patel; Lisa Saiman; Pranita D Tamma; Jason G Newland
Journal:  J Pediatric Infect Dis Soc       Date:  2018-08-17       Impact factor: 3.164

7.  Antimicrobial stewardship by academic detailing improves antimicrobial prescribing in solid organ transplant patients.

Authors:  Miranda So; Andrew M Morris; Sandra Nelson; Chaim M Bell; Shahid Husain
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-07-19       Impact factor: 3.267

8.  Reported β-Lactam and Other Antibiotic Allergies in Solid Organ and Hematopoietic Cell Transplant Recipients.

Authors:  Hannah Imlay; Elizabeth M Krantz; Erica J Stohs; Kristine F Lan; Jacqlynn Zier; H Nina Kim; Robert M Rakita; Ajit P Limaye; Anna Wald; Steven A Pergam; Catherine Liu
Journal:  Clin Infect Dis       Date:  2020-10-23       Impact factor: 20.999

Review 9.  Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention.

Authors:  Esther Benamu; Stanley Deresinski
Journal:  F1000Res       Date:  2018-01-02

Review 10.  Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions.

Authors:  Elda Righi
Journal:  World J Gastroenterol       Date:  2018-10-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.